4Vannan MA,Taylor DJE.Ventrieular remodeling after myocardial infarction[J].Br Heart J,1992,68(2):257-259.
5Hagaki J,Aoki M,Morishita,et al.In vivo evidence of the importance of cardiac angiotensin-converting enzyme in the pathogenesis of cardiac hypertrophy[J].Arterioscler Thromb Vasc Biol,2000,20(2):428-434.
6Jorge P,Kats V,Methot D,et al.Use of a biological peptide pump tO study chronic peptide hormone action in transgenic mice:direct and indirect effects of an~iotensin Ⅱ on the heart[J].J Biol Chem,2001,276(47):44012-44017.
10Simm Ang,Diez C.DenNty dependent expression of PDGF -A modulates the angiotensin Ⅱ dependent proliferation of rat cardiac fibroblasts[J].Basic Res Cardiot,1999,94(6):467-471.
二级参考文献20
1[1]Lee KL,Woodlief LH,Topol EJ,et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction[J]. Circulation,1995,91(6):1659.
2[2]Rouleau JL,Talajic M,Sussex B,et al. Myocardial infarction patients in the 1990s-their risk factors,stratification and survival in Canada:The Canadian Assessment of Myocardial Infarction (CAMI) study[J]. J Am Coll Cardiol,1996,27(5):1119.
3[3]Killip T,Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients[J]. Am J Cardiol,1967,20(4):457.
4[4]Neskovic A,Otasevic P,Bojic M,et al. Association of Killip class on admission and left ventricular dilatation[J]. Am Heart J,1999,137(2):361.
5[5]Gruppo Italiano per Io Studio della Streptochinasi nell′infarto Micardico. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction[J]. Lancet,1987,2(8564):871.
6[6]Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction[J]. N Engl J Med,1983,309(6):331.
7Boluyt M O，Cardiovasc Res，1995年，30卷，6期，836页
8W eber K T，J Mol Cell Cardiol，1995年，27卷，1期，107页
9The Consensus Trial Study Group. Effects of enalapril on mortality on severe congstive heart failure. N Engl J Med, 1987,316 : 1429-1435.
10The SOLVD Investigators. effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestion heart failure. N Engl J Med, 1991,325:293-302.
